30/10/23 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
03/08/23 GSK Nigeria calls an end to its business, to return cash RE
03/08/23 Glaxo Smithkline Consumer Nigeria To Cease Operations RE
03/08/23 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
28/04/23 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
27/01/23 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
27/01/23 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Full Year Ended December 31, 2022 CI
28/10/22 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
29/07/22 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
28/04/22 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
31/01/22 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Full Year Ended December 31, 2021 CI
25/10/21 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
29/07/21 Glaxosmithkline Consumer Nigeria plc Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Manager TitleAgeSince
Compliance Officer - -
Chief Tech/Sci/R&D Officer - 01/08/2011
General Counsel - 01/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 12.81M
-0.11%+9.94%+57.20%+148.21% 1,255B
-1.62%-0.95%+42.90%+75.88% 641B
-0.98%-0.14%+34.93%+102.23% 505B
+0.09%-2.11%+47.88%+64.62% 381B
-2.49%+2.01%+75.38%+39.94% 357B
+0.84%+2.51%+30.53%+57.24% 303B
-0.20%+7.32%+9.34%+33.30% 286B
-0.90%+2.97%+55.67%+70.93% 249B
-1.68%+5.27%+37.21%+105.26% 208B
Average +0.46%+2.95%+43.45%+77.51% 465.02B
Weighted average by Cap. +0.81%+3.90%+46.74%+93.57%
Logo GlaxoSmithKline Consumer Nigeria Plc
GlaxoSmithkline Consumer Nigeria specializes in manufacturing and marketing pharmaceutical, hygiene and health care products. Net sales break down by activity as follows: - sale of consumer healthcare products (70.7%): nutritional supplements, OTC drugs and oral care products; - sale of drugs (29.3%): antibacterial drugs, prescription drugs and vaccines.
Employees
51
  1. Stock Market
  2. Stocks
  3. GLAXOSMITH Stock